BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 31522588)

  • 1. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p.
    Qin C; Liu S; Chen W; Xue D; Guo T; Wu B
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3111-3126. PubMed ID: 37878047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Li S
    Int J Nanomedicine; 2021; 16():2803-2818. PubMed ID: 33880025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis.
    Zhu Q; Lu G; Luo Z; Gui F; Wu J; Zhang D; Ni Y
    Biochem Biophys Res Commun; 2018 Mar; 497(2):626-632. PubMed ID: 29458020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496/programmed cell death ligand 1 axis in an m6A-dependent manner.
    Yu F; Fang P; Fang Y; Chen D
    Environ Toxicol; 2024 Jun; 39(6):3721-3733. PubMed ID: 38546290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2.
    Chen X; She P; Wang C; Shi L; Zhang T; Wang Y; Li H; Qian L; Li M
    J Clin Lab Anal; 2021 Dec; 35(12):e23991. PubMed ID: 34664737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression.
    Gu X; Zhang J; Ran Y; Pan H; Jia J; Zhao Y; Zhao X; Li W; Song S; Yu X
    Cell Death Dis; 2021 Apr; 12(4):356. PubMed ID: 33824281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0061395 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1182 sponge.
    Wu W; Zhou Z; Chen C; Chen M
    Cell Cycle; 2022 Oct; 21(20):2192-2205. PubMed ID: 35775884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
    Tian YS; Zhong D; Liu QQ; Zhao XL; Sun HX; Jin J; Wang HN; Li GZ
    J Neurosurg; 2018 Mar; 130(3):977-988. PubMed ID: 29521586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission.
    Yan J; Wang X; Fan Z; Xu Y; Zhang Y; Liu Y; Guo L; Liu D
    Apoptosis; 2024 Jun; 29(5-6):709-725. PubMed ID: 38459420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate
    Wu M; Sun T; Xing L
    Cancer Biother Radiopharm; 2023 Dec; 38(10):708-719. PubMed ID: 33021399
    [No Abstract]   [Full Text] [Related]  

  • 18. Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2.
    Chen Y; Li S; Wei Y; Xu Z; Wu X
    Bosn J Basic Med Sci; 2021 Oct; 21(5):555-568. PubMed ID: 33714261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
    Wang K; Lu Q; Luo Y; Yu G; Wang Z; Lin J; Tan Z; Lao Y; Liu S; Yang H
    Biol Direct; 2024 Jan; 19(1):4. PubMed ID: 38163874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.